NCTY and RFAI Related Headlines
Go Back- The9 Reports US$32 Million Net Income for Second Quarter of 2026, Up Over 39% Sequentially
- AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing
- The9 investee NYB plans $1.5 billion SPAC merger to go public
- The9's Singapore Investee NYB Announce Plan to Go Nasdaq via US$1.5 Billion Business Combination with SPAC RF Acquisition Corp II
NCTY and RFAI Related Press Releases
Go Back- The9 Reports US$32 Million Net Income for Second Quarter of 2026, Up Over 39% Sequentially
- AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing
- The9's Singapore Investee NYB Announce Plan to Go Nasdaq via US$1.5 Billion Business Combination with SPAC RF Acquisition Corp II
